These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 7607576)

  • 1. The involvement of the chromosome 11q13 region in human malignancies: cyclin D1 and EMS1 are two new candidate oncogenes--a review.
    Schuuring E
    Gene; 1995 Jun; 159(1):83-96. PubMed ID: 7607576
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification and cloning of two overexpressed genes, U21B31/PRAD1 and EMS1, within the amplified chromosome 11q13 region in human carcinomas.
    Schuuring E; Verhoeven E; Mooi WJ; Michalides RJ
    Oncogene; 1992 Feb; 7(2):355-61. PubMed ID: 1532244
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of cyclin D1 and EMS1 in bladder tumours; relationship with chromosome 11q13 amplification.
    Bringuier PP; Tamimi Y; Schuuring E; Schalken J
    Oncogene; 1996 Apr; 12(8):1747-53. PubMed ID: 8622895
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MYEOV: a candidate gene for DNA amplification events occurring centromeric to CCND1 in breast cancer.
    Janssen JW; Cuny M; Orsetti B; Rodriguez C; Vallés H; Bartram CR; Schuuring E; Theillet C
    Int J Cancer; 2002 Dec; 102(6):608-14. PubMed ID: 12448002
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amplification of cyclin D1 in squamous cell carcinoma of the head and neck and the prognostic value of chromosomal abnormalities and cyclin D1 overexpression.
    Akervall JA; Michalides RJ; Mineta H; Balm A; Borg A; Dictor MR; Jin Y; Loftus B; Mertens F; Wennerberg JP
    Cancer; 1997 Jan; 79(2):380-9. PubMed ID: 9010112
    [TBL] [Abstract][Full Text] [Related]  

  • 6. EMS1 amplification can occur independently of CCND1 or INT-2 amplification at 11q13 and may identify different phenotypes in primary breast cancer.
    Hui R; Campbell DH; Lee CS; McCaul K; Horsfall DJ; Musgrove EA; Daly RJ; Seshadri R; Sutherland RL
    Oncogene; 1997 Sep; 15(13):1617-23. PubMed ID: 9380415
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-throughput tissue microarray analysis of 11q13 gene amplification (CCND1, FGF3, FGF4, EMS1) in urinary bladder cancer.
    Zaharieva BM; Simon R; Diener PA; Ackermann D; Maurer R; Alund G; Knönagel H; Rist M; Wilber K; Hering F; Schönenberger A; Flury R; Jäger P; Fehr JL; Mihatsch MJ; Gasser T; Sauter G; Toncheva DI
    J Pathol; 2003 Dec; 201(4):603-8. PubMed ID: 14648664
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclin D1, EMS1 and 11q13 amplification in breast cancer.
    Ormandy CJ; Musgrove EA; Hui R; Daly RJ; Sutherland RL
    Breast Cancer Res Treat; 2003 Apr; 78(3):323-35. PubMed ID: 12755491
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amplification of EMSY, a novel oncogene on 11q13, in high grade ovarian surface epithelial carcinomas.
    Brown LA; Irving J; Parker R; Kim H; Press JZ; Longacre TA; Chia S; Magliocco A; Makretsov N; Gilks B; Pollack J; Huntsman D
    Gynecol Oncol; 2006 Feb; 100(2):264-70. PubMed ID: 16236351
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chromosome 11q13 markers and D-type cyclins in breast cancer.
    Peters G; Fantl V; Smith R; Brookes S; Dickson C
    Breast Cancer Res Treat; 1995; 33(2):125-35. PubMed ID: 7749140
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amplification and overexpression of the EMS 1 oncogene, a possible prognostic marker, in human hepatocellular carcinoma.
    Yuan BZ; Zhou X; Zimonjic DB; Durkin ME; Popescu NC
    J Mol Diagn; 2003 Feb; 5(1):48-53. PubMed ID: 12552080
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression and tyrosine phosphorylation of EMS1 in human breast cancer cell lines.
    Campbell DH; deFazio A; Sutherland RL; Daly RJ
    Int J Cancer; 1996 Nov; 68(4):485-92. PubMed ID: 8945620
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene products of chromosome 11q and their association with CCND1 gene amplification and tamoxifen resistance in premenopausal breast cancer.
    Lundgren K; Holm K; Nordenskjöld B; Borg A; Landberg G
    Breast Cancer Res; 2008; 10(5):R81. PubMed ID: 18823530
    [TBL] [Abstract][Full Text] [Related]  

  • 14. EMS1 gene expression in primary breast cancer: relationship to cyclin D1 and oestrogen receptor expression and patient survival.
    Hui R; Ball JR; Macmillan RD; Kenny FS; Prall OW; Campbell DH; Cornish AL; McClelland RA; Daly RJ; Forbes JF; Blamey RW; Musgrove EA; Robertson JF; Nicholson RI; Sutherland RL
    Oncogene; 1998 Aug; 17(8):1053-9. PubMed ID: 9747885
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A region within murine chromosome 7F4, syntenic to the human 11q13 amplicon, is frequently amplified in 4NQO-induced oral cavity tumors.
    Yuan B; Oechsli MN; Hendler FJ
    Oncogene; 1997 Sep; 15(10):1161-70. PubMed ID: 9294609
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amplification of chromosome band 11q13 and a role for cyclin D1 in human breast cancer.
    Dickson C; Fantl V; Gillett C; Brookes S; Bartek J; Smith R; Fisher C; Barnes D; Peters G
    Cancer Lett; 1995 Mar; 90(1):43-50. PubMed ID: 7720042
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The product of the EMS1 gene, amplified and overexpressed in human carcinomas, is homologous to a v-src substrate and is located in cell-substratum contact sites.
    Schuuring E; Verhoeven E; Litvinov S; Michalides RJ
    Mol Cell Biol; 1993 May; 13(5):2891-98. PubMed ID: 8474448
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclin D1 (PRAD1, CCND1) and glutathione-S-transferase pi gene expression in head and neck squamous cell carcinoma.
    Gaffey MJ; Iezzoni JC; Meredith SD; Boyd JC; Stoler MH; Weiss LM; Zukerberg LR; Levine PA; Arnold A; Williams ME
    Hum Pathol; 1995 Nov; 26(11):1221-6. PubMed ID: 7590696
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PRAD-1 (CCND1)/cyclin D1 oncogene amplification in primary head and neck squamous cell carcinoma.
    Callender T; el-Naggar AK; Lee MS; Frankenthaler R; Luna MA; Batsakis JG
    Cancer; 1994 Jul; 74(1):152-8. PubMed ID: 8004570
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PRAD-1/cyclin D1 gene amplification correlates with messenger RNA overexpression and tumor progression in human laryngeal carcinomas.
    Jares P; Fernández PL; Campo E; Nadal A; Bosch F; Aiza G; Nayach I; Traserra J; Cardesa A
    Cancer Res; 1994 Sep; 54(17):4813-7. PubMed ID: 8062283
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.